Can Kopin Corporation Kopn Stock Double In 2026 Price At 2.67 Down 0.41 20260410 Reviva Pharmaceuticals RVPH Q1 2026 Earnings EPS Beats Estimates as Cost Discipline Drives SmallerThanExpected Loss KOSS Q1 2026 Earnings Negative EPS and Stock Decline Highlight Persistent Headwinds DRCT Q1 2026 Earnings EPS Beats Estimates Despite Negative Results QUAD Q1 2026 Earnings EPS Beat Underpins Cost Discipline Stock Edges Higher Guardian Pharmacy Services Inc GRDN Q1 2026 Earnings EPS Misses Estimates as Pharmacy Operations Face Margin Pressure FITBM Q1 2026 Earnings Strong EPS Surprise of 3509 Outperforms Estimates